Motor fluctuations and dyskinesia in Parkinson's disease.
about
Available and emerging treatments for Parkinson's disease: a reviewDeep Brain Stimulation: A Paradigm Shifting Approach to Treat Parkinson's DiseaseDrug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?Restoration of the Dopamine Transporter through Cell Therapy Improves Dyskinesia in a Rat Model of Parkinson's DiseaseMRI-Guided Focused Ultrasound in Parkinson's Disease: A ReviewTranscriptome analysis in a rat model of L-DOPA-induced dyskinesiaClinical aspects of palliative care in advanced Parkinson's disease.Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian miceThe safety and efficacy of safinamide mesylate for the treatment of Parkinson's disease.Verbal Memory Decline following DBS for Parkinson's Disease: Structural Volumetric MRI Relationships.Acute administration of L-DOPA induces changes in methylation metabolites, reduced protein phosphatase 2A methylation, and hyperphosphorylation of Tau protein in mouse brain.RNA knockdown as a potential therapeutic strategy in Parkinson's disease.Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER.Evaluation of the D3 dopamine receptor selective antagonist PG01037 on L-dopa-dependent abnormal involuntary movements in ratsIndependent Spanish Validation of the Unified Dyskinesia Rating Scale.The yin and yang of VEGF and PEDF: multifaceted neurotrophic factors and their potential in the treatment of Parkinson's Disease.Therapeutic options for continuous dopaminergic stimulation in Parkinson's diseaseSafinamide for the treatment of Parkinson's disease.Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease.Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease.Differential behavioral outcomes following neonatal versus fetal human retinal pigment epithelial cell striatal implants in parkinsonian rats.Which dyskinesia scale best detects treatment response?Neonatal human retinal pigment epithelial cells secrete limited trophic factors in vitro and in vivo following striatal implantation in parkinsonian rats.Earlier Intervention with Deep Brain Stimulation for Parkinson's Disease.Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's disease.Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-induced behavioral sensitization in dyskinetic rats.Lifestyle regularity measured by the social rhythm metric in Parkinson's disease.Sequence variants in SLC6A3, DRD2, and BDNF genes and time to levodopa-induced dyskinesias in Parkinson's disease.Behavioural cues of personality in Parkinson's disease.Postural Control and Somatosensory Information: Effects of Aging and Parkinson’s Disease
P2860
Q24633444-036622F6-BA25-4AD9-B878-8C3A3A8A354BQ26747575-4D6A918E-99B3-4A5C-B30A-2DE75C6B12BDQ27021464-99C7DC7C-E918-4A22-A6AD-5EE9CA85D71CQ27314456-D8F2BE85-9668-45BE-9CDA-0C52F889296FQ30357442-A7D27DB4-7679-47D1-88D8-5E48703E86C0Q34400095-C3D46599-0EE8-41D5-A2B6-05EA73D8CCFCQ34457767-98D38077-8A5A-4CD6-8242-6D5DD863470BQ34490801-804761B2-9780-4A6D-A23A-1BF01A60F30CQ34512544-1C2B56D9-FA19-42A8-B7E6-FBCE86E256FDQ36111586-F53572F8-DDCA-41F1-884F-71E52FB2FE59Q36174698-747F1A12-FB59-4543-94D0-44E62AB31CBAQ36305419-258C4C07-474D-41A6-AFB9-E39B3D45527CQ36941752-303CA1E9-A47D-4897-95A2-274F5493FFC1Q37286573-A1374C01-351D-463C-9FE8-449363DFE59CQ37441475-210A1741-29D4-4C4C-84A3-D556815F9439Q37820210-07180BD7-CAA0-43A0-9D4F-36382F24C194Q37823337-AD0CDBC9-7FD8-424A-B9C0-25D464E338D9Q38258514-CDF74CD2-2C4B-4BAF-B618-FA34BF8894DDQ38839079-145367C5-2D1C-40EB-8D7C-BA2961C01EB0Q38877254-40B8F1E7-5067-454D-9A17-292A234F3A0CQ38979736-C678BF8F-07AA-4B19-8B12-C458C6D3D86DQ39471220-A6D362B9-3369-47BE-B68E-53799C1F0519Q40347098-4CE15185-A242-49B4-99BF-2ADB229CC46DQ41690001-963A1F4A-17DF-4003-9A27-1AD89AC5741AQ45985296-BB717968-FC4C-48EA-9CE8-D149C0961639Q46778385-7A8AB760-E58C-4C3D-B6A0-D025BAD0B864Q48524014-99143310-28DA-4096-BDB8-96F81160EF71Q48880365-5074AAE1-F399-4927-B118-FB15C16B396CQ52089064-C3939FD9-DE3D-403A-B18C-3DC7C2AE4D12Q58215190-A7595CD9-72C9-46C4-9BBC-53530D7452A0
P2860
Motor fluctuations and dyskinesia in Parkinson's disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Motor fluctuations and dyskinesia in Parkinson's disease.
@ast
Motor fluctuations and dyskinesia in Parkinson's disease.
@en
Motor fluctuations and dyskinesia in Parkinson's disease.
@nl
type
label
Motor fluctuations and dyskinesia in Parkinson's disease.
@ast
Motor fluctuations and dyskinesia in Parkinson's disease.
@en
Motor fluctuations and dyskinesia in Parkinson's disease.
@nl
prefLabel
Motor fluctuations and dyskinesia in Parkinson's disease.
@ast
Motor fluctuations and dyskinesia in Parkinson's disease.
@en
Motor fluctuations and dyskinesia in Parkinson's disease.
@nl
P1476
Motor fluctuations and dyskinesia in Parkinson's disease.
@en
P2093
P304
P356
10.1016/S1353-8020(01)00024-4
P577
2001-10-01T00:00:00Z